Literature DB >> 26827158

Ability to detect high-grade squamous anal intraepithelial lesions at high resolution anoscopy improves over time.

Richard J Hillman1, Manoji P W Gunathilake1, Fengyi Jin2, Winnie Tong3, Andrew Field4, Andrew Carr3.   

Abstract

UNLABELLED: Background Anal cancer is increasing in incidence, has very high rates in specific populations and shares many similarities with cervical cancer. High-grade squamous intraepithelial lesions (HSIL) are regarded as precursors to anal cancer. High resolution anoscopy (HRA), which is derived from colposcopy, is the only currently available tool that can identify areas of the anal canal for targeted biopsy and identification of HSIL.
METHODS: This study investigated the ability over a period of time of a single anoscopist to identify and adequately biopsy HSIL, correlating with contemporary anal cytological findings.
RESULTS: Four hundred paired cytology and histology samples collected from 283 patients over a 7-year period from 2004 to 2010 were compared. There was a significant increase in HSIL detection rates when anal squamous cells of undetermined significance (ASC-US; 38.6-66.0%) or low-grade squamous intra-epithelial lesion (38.8-68.3%) were taken as cut-off points (P<0.001 for both). Detection rates did not change significantly when atypical squamous cells-cannot exclude HSIL (ASC-H) or a higher grade lesion (70-76.6%) was taken as the cut-off point.
CONCLUSIONS: The increase in ability to detect histological HSIL over time and with increasing experience has the potential to impact on delivery of clinical services and the interpretation of clinical trial data. Further studies are required to determine the extent of this effect on other clinicians practising HRA.

Entities:  

Mesh:

Year:  2016        PMID: 26827158     DOI: 10.1071/SH15170

Source DB:  PubMed          Journal:  Sex Health        ISSN: 1448-5028            Impact factor:   2.706


  6 in total

1.  A Randomized Clinical Trial of Infrared Coagulation Ablation Versus Active Monitoring of Intra-anal High-grade Dysplasia in Adults With Human Immunodeficiency Virus Infection: An AIDS Malignancy Consortium Trial.

Authors:  Stephen E Goldstone; Shelly Y Lensing; Elizabeth A Stier; Teresa Darragh; Jeannette Y Lee; Annemieke van Zante; Naomi Jay; J Michael Berry-Lawhorn; Ross D Cranston; Ronald Mitsuyasu; David Aboulafia; Joel M Palefsky; Timothy Wilkin
Journal:  Clin Infect Dis       Date:  2019-03-19       Impact factor: 9.079

2.  Electrocautery ablation of anal high-grade squamous intraepithelial lesions: Effectiveness and key factors associated with outcomes.

Authors:  Michael M Gaisa; Yuxin Liu; Ashish A Deshmukh; Kimberly L Stone; Keith M Sigel
Journal:  Cancer       Date:  2020-01-24       Impact factor: 6.860

3.  High-resolution anoscopy in HIV-infected men: Assessment of the learning curve and factors that improve the performance.

Authors:  Karin Neukam; Yusnelkis Milanés Guisado; María Fontillón; Laura Merino; César Sotomayor; Nuria Espinosa; Luis F López-Cortés; Pompeyo Viciana
Journal:  Papillomavirus Res       Date:  2019-02-01

4.  Humoral Response to HPV16 Proteins in Persons with Anal High-Grade Squamous Intraepithelial Lesion or Anal Cancer.

Authors:  Helen C Stankiewicz Karita; Tim Waterboer; Amalia Magaret; David R Doody; Michael Pawlita; Nicole Brenner; Denise A Galloway; Anna Wald; Margaret M Madeleine
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-09-03       Impact factor: 4.090

5.  The acceptability of high resolution anoscopy examination in patients attending a tertiary referral centre.

Authors:  Anke De-Masi; Esther Davis; Tamzin Cuming; Noreen Chindawi; Francesca Pesola; Carmelina Cappello; Susan Chambers; Julie Bowring; Adam N Rosenthal; Peter Sasieni; Mayura Nathan
Journal:  BMC Cancer       Date:  2018-05-11       Impact factor: 4.430

6.  Risk factors for anal high-grade squamous intraepithelial lesions in HIV-positive MSM: is targeted screening possible?

Authors:  Matthijs L Siegenbeek van Heukelom; Elske Marra; Henry J C de Vries; Maarten F Schim van der Loeff; Jan M Prins
Journal:  AIDS       Date:  2017-10-23       Impact factor: 4.177

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.